Stereotaxis Inc. said the FDA cleared its magnetically tipped PowerAssert radiofrequency (RF) guide wire to cross chronic total occlusions (CTOs) in the peripheral vasculature.
Boston Scientific's TAXUS Express2 Atom paclitaxel-eluting coronary stent system is a drug-eluting stent (DES) specifically designed for treating small coronary vessels. The TAXUS Express2 Atom Stent System is the only DES approved by the FDA for use in vessels as small as 2.25 mm in diameter, Boston Scientific said. The Taxus Express 2 Atom received FDA approval in the fall of 2008.
October 31, 2008 - Corgenix Medical Corp. recently said new CHARISMA trial findings published in Circulation confirm ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Cardiovascular care does not occur in a single hospital setting; more often than not patients undergo a variety of tests at different locations. In order to provide the best care possible, physicians need immediate access to all patient information, no matter where, when or how it was obtained.
October 30, 2008 - Abbott this week received a 2008 Chicago Innovation Award for its XIENCE V Everolimus Eluting ...
There have been numerous new products released in the past year to enhance implantable pacing and defibrillation devices, but new advances in remote monitoring seem to be paving the way of the future.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
October 30, 2008 - CHF Solutions said seven studies supporting ultrafiltration therapy’s effectiveness and benefits in ...
October 30, 2008 - Thinking Systems is debuting at RSNA 2008 its new release of the company’s unified Web-based ThinkingPACS/ThinkingRIS with comprehensive solutions for radiology, cardiology and molecular imaging.
October 30, 2008 - C. R. Bard Inc. today received approval from the FDA to market the Flair Endovascular Stent Graft with an optimized delivery system.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
October 30, 2008 - Thoratec Corp. this week notified healthcare professionals of a worldwide correction of the HeartMate ...
There is skepticism among cardiologists whether flat panel detectors can help lower the X-ray dose more than using traditional image intensifiers in the cath lab. There was a story concerning this in the last issue of DAIC which said flat panel detectors are replacing image intensifiers partly because they help lower the X-ray exposure to patients.
October 29, 2008 - Nearly 18 months of data from Cappella’s Sideguard I and II self-expanding side branch heart stent in ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
October 29, 2008 - Critical Diagnostics today announced the publication of a research paper and an accompanying ...
Oxilan (Ioxilan Injection) is a contrast media for use in peripheral procedures because of its viscosity. Its reported low viscosity allows it to reach distal vessels. It also has the lowest osmolality of all nonionic monomers in the U.S. Together, these properties facilitate ease of injection, help improve patient comfort and provide visualization and image quality.
OASIS 1.2T MRI is designed to deliver high performance and patient comfort. The Oasis open architecture, High-Field strength, Zenith RF technology and fast gradients drive diagnostic confidence and image quality.
October 30, 2008
